Sabrina Annick Assoumou MD, MPH
Inaugural Louis W. Sullivan, MD Professor of Medicine
Assistant Professor, Infectious Diseases
771 Albany St | (617) 414-5282
Sabrina A. Assoumou, MD MPH, is the inaugural Louis W. Sullivan, MD, Professor of Medicine and Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine. She is also an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for patients with human immunodeficiency virus (HIV) at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.
Dr. Assoumou has published in multiple journals including Clinical Infectious Diseases, AIDS, Annals of Internal Medicine and the Journal of American Medical Association. Her work has also been included in the American Association for the Study of Liver Diseases (AASLD)/ Infectious Diseases Society of America (IDSA) recommendations for testing, managing and treating HCV (Assoumou et al., Clin Infect Dis 2018) as well as HCV testing recommendations by the Centers for Disease Control and Prevention (Assoumou et al., Clin Infect Dis 2018 and Assoumou et al., Clin Infect Dis. 2019). Dr. Assoumou has also presented her findings at the National Academy of Sciences to the panel tasked with developing a National Strategy for the Elimination of Hepatitis B and C and at international scientific meetings such as IDWeek and the Conference on Retroviruses and Opportunistic Infections (CROI).
Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health. Dr. Assoumou received an Excellence in Teaching Hospital-Based Faculty Award at BMC in 2017. She was also recognized as the Distinguished Faculty of the Month in April 2020 for her service to the BUSM community in teaching, service on committees, mentoring of students, trainees and junior faculty. The same year she also received a Department of Medicine Evans Junior Faculty Research Merit Award recognizing an outstanding record of scholarship and research. Dr. Assoumou’s impact on the medical campus and beyond culminated in 2021 in her installation as the inaugural Louis W. Sullivan, MD, Professor of Medicine which honors Dr. Sullivan’s contributions to his alma mater – Chobanian and Avedisian School of Medicine and to the medical field as former Health and Human Services Secretary and the first Dean of Morehouse Medical School.
Dr. Assoumou has also contributed to COVID 19-related efforts as part of the NIH-funded Massachusetts Community Engagement Alliance (MA-CEAL), and the Commonwealth of Massachusetts’ “Trust the Facts, Get the Vax” public awareness campaign. Further, she was appointed by Mayor Michelle Wu to the City of Boston’s COVID-19 Advisory Committee. She has also become a trusted source for local, national and international news outlets such as BBC Worldwide, ABC Australia, NBC News, Reuters, Bloomberg, Newsweek, TIME, PBS, The Boston Globe, The Bay State Banner, Boston 25 as well as local NPR affiliates WBUR and WGBH.
Sabrina Assoumou Named Louis W. Sullivan, MD, Professor of Medicine
Medicine-Pediatrics, MD, University of Rochester School of Medicine & Dentistry, 2004
Clinical Evaluation/Research, MPH, Harvard School of Public Health, 2013
Biology, BA, Williams College, 1999
Martin AK, Perryman T, Bernstein JA, Taylor JL, Cruz R, Muroff J, Samet JH, Assoumou SA. Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study. Drug Alcohol Depend Rep. 2023 Jun; 7:100156. PMID: 37113387.Published on 3/22/2023
McLaughlin A, Burns R, Ryan M, Abbasi W, Harvey L, Hicks J, Sinha P, Assoumou SA. Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study. Subst Abuse. 2023; 17:11782218231160014. PMID: 36968974.Published on 3/22/2023
McLaughlin A, Burns R, Ryan M, Abbasi W, Harvey L, Hicks J, Sinha P, Assoumou SA. Comparing COVID-19-related Morbidity and Mortality Between Patients With and Without Substance Use Disorders: A Retrospective Cohort Study. Subst Abuse. 2023; 17:11782218231160014. PMID: 36968974.Published on 3/10/2023
Tamlyn AL, Tjilos M, Bosch NA, Barnett KG, Perkins RB, Walkey A, Assoumou SA, Linas BP, Drainoni ML. At the intersection of trust and mistrust: A qualitative analysis of motivators and barriers to research participation at a safety-net hospital. Health Expect. 2023 Jun; 26(3):1118-1126. PMID: 36896842.Published on 2/16/2023
Tjilos M, Tamlyn AL, Ragan EJ, Assoumou SA, Barnett KG, Martin P, Perkins RB, Linas BP, Drainoni ML. "Community members have more impact on their neighbors than celebrities": leveraging community partnerships to build COVID-19 vaccine confidence. BMC Public Health. 2023 Feb 16; 23(1):350. PMID: 36797724.Published on 2/5/2023
Karanika S, Karantanos T, Carneiro H, Assoumou SA. Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients. Cells. 2023 Feb 05; 12(4). PMID: 36831190.Published on 2/1/2023
Childs E, Yoloye K, Bhasin RM, Benjamin EJ, Assoumou SA. Retaining Faculty from Underrepresented Groups in Academic Medicine: Results from a Needs Assessment. South Med J. 2023 Feb; 116(2):157-161. PMID: 36724529.Published on 1/31/2023
Bor J, Assoumou SA, Lane K, Diaz Y, Ojikutu BO, Raifman J, Levy JI. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study. PLoS Med. 2023 Jan; 20(1):e1004167. PMID: 36719864.Published on 12/16/2022
Zambrano S, Davis M, Leeds DR, Noronha K, McLaughlin A, Burns RH, Mulvey E, Linas BP, Assoumou SA. Laboratory test trends within 72 hours of hospital admission associated with death among COVID-19 patients. Medicine (Baltimore). 2022 Dec 16; 101(50):e31154. PMID: 36550914.Published on 11/1/2022
Morgan JR, Murphy SM, Assoumou SA, Linas BP. Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees. J Occup Environ Med. 2022 Nov 01; 64(11):899-904. PMID: 35901222.
Published on 5/11/2023
Ask The Docs: the COVID emergency ends, and a new RSV vaccine in the works
Published on 5/10/2023
As the COVID PHE Ends, Here's What Doctors Are Carrying Forward
Published on 5/8/2023
Massachusetts' COVID Emergency Ends Thursday: What It Means for You
Published on 5/6/2023
‘I try not to let it scare me:’ COVID-19 emergency to end, but anxiety lingers
Published on 4/21/2023
Boston area wastewater numbers continue downward trend
Published on 4/11/2023
‘A Much Better Place': Top Boston Doctors Explain Mass. COVID Rates, Wastewater Data
Published on 4/3/2023
Published on 3/29/2023
Study: Substance Use Disorders Do Not Increase Likelihood of COVID-19 Deaths
Published on 3/23/2023
Stomach Bug? It could be norovirus
Published on 3/21/2023
Three years after COVID-19 was declared a pandemic, how cautious are the experts?View full list of 267 media mentions.